Supportive Oncology

Excellent work by @DrAndreaLSmith, examining the minimal involvement of people with advanced/metastatic cancer in survivorship studies in Australia - 5 recommendations provided to increase focus and representation of this high need survivorship population: link.springer.com/epdf/10.1007/s…

RT @DrNicolasHart: Feasibility and implementation outcomes of our global Phase III RCT examining vigorous exercise for survival in advanced…

RT @DrNicolasHart: Our first article for 2026 - planning for ‘when’ and not ‘if’ we get cancer - through building accessible and high-quali…

What a lovely way it was to finish the year's conferences with #COSAIPOS2025! Great to have a few of our @UTSEngage @UTS_Health Cancer Survivorship Group members busy as always with giving invited talks, chairing multiple sessions, and presenting posters. @DrNicolasHart

Some of our @UTS_Health Cancer Survivorship team at the #COSAIPOS2025 conference - presenting work on prehabilitation (CALD communities), Cancer-Related Cognitive Impairment, and of course, Chairing sessions - amazing work as always by @DarrenHaywood14, @_JamesMurray_EP, and Jen!

Extremely honoured to be the next Editor-in-Chief of the Asia-Pacific Journal of Clinical Oncology (AJCO), alongside Founding Editor-in-Chief, Professor Stephen Ackland. It’s particularly fantastic to have co-EIC’s from across clinical oncology and cancer survivorship fields!

Pleased to receive @COSAoncology endorsement of the @CancerCareMASCC COG-IMPACT Tool. 🔗 Read our new editorial: onlinelibrary.wiley.com/doi/10.1111/aj… In this editorial, we offer clinical and research implementation and future research directions related to the MASCC COG-IMPACT, as well as

🚨 Job Posting 🚨 - Lecturer in Clinical Exercise Physiology (0.5 FTE) ongoing basis - the best of both worlds, as a part-time lecturer at @UTSEngage. Located at the beautiful Moore Park Precinct - role that encourages you to remain an active clinician: lnkd.in/gpRUTrfD

COSA is pleased to endorse the Survivorship Care for People Affected by Advanced or Metastatic Cancer: MASCC-ASCO Standards and Practice Recommendations. bit.ly/44JLN0A Read the endorsement paper from @DrNicolasHart and his co-authors at bit.ly/3GINjIi

I’m often asked whose responsibility it is to provide cancer survivorship care. My answer? - It’s everyone’s responsibility (not a single health professional or profession)! This excellent paper by @realbowtiedoc, provides Top Ten Tips for Palliative Care: pubmed.ncbi.nlm.nih.gov/40620208/

Pleased to have @COSAoncology endorsement of the @CancerCareMASCC and @ASCO Standards and Practice Recommendations for Advanced or Metastatic Cancer Survivorship Care: onlinelibrary.wiley.com/doi/epdf/10.11…. In this editorial, we offer implementation and future optimal care considerations.

Fantastic to have been involved in this magnificent panel, facilitated by the eminent @JulieMcCrossin, and co-presented with colleagues Prof @Hagsie, @DrMonicaTang, and Dr Michael Krasovitsky, with a strong cameo from @Bogda_Koczwara fresh from the airport to summarise the field.

Our new paper, led by @CancerCareMASCC Survivorship Fellow, @NaomiTakemura - introducing the ‘treatable traits’ paradigm to cancer care: #Tab1" target="_blank" rel="nofollow noopener">link.springer.com/article/10.100… A treatable trait must:- 1. Have Clinical Relevance. 2. Identifiable and Measurable. 3. Evidence-based Interventions.

Looking forward to present on the important topic of cancer survivorship for #WolperJewishHospital, facilitated by @JulieMcCrossin, with an all-star Sydney cast including Prof @Hagsie, Dr Michael Krasovitsky, and @DrMonicaTang.

A standing ovation for #CHALLENGE trial at #ASCO25 - first in world to definitively show exercise reduces recurrence and improves survival: “For every 16 people, exercise prevents 1 person from recurrent/new cancer” “For every 14 people, exercise prevents 1 person from dying”

🚨Big News🚨from #ASCO25: 🟢 Definitive Phase III RCT 🟢 Structured Aerobic Exercise (3-years) 🟢 Stage II-III Colorectal Cancer 🟢 Post-Adjuvant Chemotherapy 💪🏽 Longer Disease-Free Survival 💪🏽 Improved Overall Survival 💪🏽 Less Cancer Recurrence 💪🏽 Less New Primary Cancers

RT @DrNicolasHart: What does survivorship care look like for people affected by advanced or metastatic cancer? What can we do now? What sha…

A real pleasure to spend more time with @DrAndreaLSmith discussing our collective work on (and Andrea’s lived experience with) metastatic cancer survivorship, with the pre-eminent Bogda Koczwara on her #SupportiveCareMatters oncology podcast: oncologynews.com.au/clinical-focus…

Building on our recent MASCC-ASCO Survivorship Care Standards for People affected by Advanced or Metastatic Cancer (ascopubs.org/doi/10.1200/ED…), we provide suggestions for stakeholders, and opportunities to expand clinical care, research, and advocacy across resource settings.

Our collection (special issue) on Cancer-Related Fatigue in @MASCC_JSCC is open for submissions (with 3 papers in 2025 already published): link.springer.com/collections/bd… - Co-edited by @CancerCareMASCC’s Chair and Vice-Chair of Fatigue (@DrNicolasHart and @Amber_Kleckner.